Literature DB >> 23461311

Association of anti-IL-12/23 biologic agents ustekinumab and briakinumab with major adverse cardiovascular events.

T Tzellos1, A Kyrgidis, A Trigoni, C C Zouboulis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23461311     DOI： 10.1111/jdv.12126

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  3 in total

1.  [Phototherapy in the era of biologicals].

Authors:  P Lehmann
Journal:  Hautarzt       Date:  2013-05       Impact factor: 0.751

2.  Short-term risk of major adverse cardiovascular events or congestive heart failure in patients with psoriatic arthritis or psoriasis initiating a biological therapy: a meta-analysis of randomised controlled trials.

Authors:  Bénédicte Champs; Yannick Degboé; Thomas Barnetche; Alain Cantagrel; Adeline Ruyssen-Witrand; Arnaud Constantin
Journal:  RMD Open       Date:  2019-01-24

Review 3.  Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis.

Authors:  Chih-Fan Yeh; Ying-Hsien Chen; Sheng-Fu Liu; Hsien-Li Kao; Ming-Shiang Wu; Kai-Chien Yang; Wei-Kai Wu
Journal:  Int J Mol Sci       Date:  2020-11-19       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.